Evidence map›Paper›PMID 34355129›Full record

ArticleMayo Clinic proceedings. Innovations, quality & outcomes2021

Deprescribing in Hospice Patients: Discontinuing Aspirin, Multivitamins, and Statins.

Cari E Low, Daniel E Sanchez Pellecer, Wil L Santivasi, Virginia H Thompson, Theresa Elwood, Ashly J Davidson, Julie A Tlusty, Molly A Feely, Cory Ingram

Open access · goldAbstract read
In one paragraph

Article in Mayo Clinic proceedings. Innovations, quality & outcomes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Perspectives on deprescribing in palliative care.Expert review of clinical pharmacology · 2023
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Cari E LowMayo Clinic School of Graduate Medical Education, Mayo Clinic College of Medicine and Science, Rochester, MN.
Daniel E Sanchez PellecerMayo Clinic School of Graduate Medical Education, Mayo Clinic College of Medicine and Science, Rochester, MN.
Wil L SantivasiMayo Clinic School of Graduate Medical Education, Mayo Clinic College of Medicine and Science, Rochester, MN.
Virginia H ThompsonMayo Clinic Hospice, Mayo Clinic, Rochester, MN.
Theresa ElwoodMayo Clinic Hospice, Mayo Clinic, Rochester, MN.
Ashly J DavidsonMayo Clinic Hospice, Mayo Clinic, Rochester, MN.
Julie A TlustyMayo Clinic Hospice, Mayo Clinic, Rochester, MN.
Molly A FeelyCenter for Palliative Medicine, Mayo Clinic, Rochester, MN.
Cory IngramCenter for Palliative Medicine, Mayo Clinic, Rochester, MN.
Mayo Clinic in Arizona · USMayo Clinic · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo facilitate deprescribing of aspirin, multivitamins, and statins in hospice patients enrolled in Mayo Clinic Hospice, Rochester, Minnesota. PATIENTS AND

methodsDuring the fall of 2019, we conducted a quality improvement project to improve care of Mayo Clinic Hospice patients by decreasing the percentage of patients taking aspirin, multivitamins, or statins. Project interventions included the addition of a palliative medicine fellow to the hospice interdisciplinary team, nurse education, and implementation of an evidence-based deprescribing resource tool. The resource tool included a communication framework to guide deprescribing conversations and a literature summary supporting deprescribing. The project team recorded the number of patients taking 1 of these medications by intermittently surveying the hospice census. Process and counterbalance measures were tracked with online surveys of hospice nursing staff.

resultsAt the start of the project, 22 of 69 patients (32%) were taking aspirin, a multivitamin, or a statin. After introduction of the deprescribing resource tool and the addition of a palliative medicine fellow to the interdisciplinary team, this was reduced to 20 of 83 patients (24%), a 24% decrease. Results appeared to be driven primarily by a reduction in multivitamin use (33% decrease). Self-reported comfort and knowledge about deprescribing improved among the hospice nursing staff, as did satisfaction in their workflow from 5.4 to 6.0 (maximum, 7).

conclusionThe addition of a dedicated team member to address medication issues and provision of an evidence-based deprescribing resource tool appear to reduce the use of unnecessary and potentially harmful medications in ambulatory hospice patients.

Indexed as

PDSA, Plan-Do-Study-Act

Identifiers

PMID34355129
PMCPMC8325098
OpenAlexW3183253408

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.